Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

TIBOK

Mauritian AI-native healthcare operating system — Eva assistant plus sourced clinical intelligence — sold pay-per-consultation and white-labelled to distributors.

Open the dossier
Opportunities
5
High confidence
070% and above
Counterparts
5startups and investors
  • Distribution 1
  • Market entry 1
  • Co-development 2
  • Investors 1

Distribution1

A channel or customer base to reach together

Offer VytalBridge mothers a doctor-backed care layer in Southern Africa

VytalBridge builds a siSwati-first maternal monitoring app and clinical hub but has no doctor network or prescriptions; TIBOK provides teleconsultation, labs and prescriptions under white label. Together they form a complete maternal-care offer for Eswatini and Botswana.

20%confidence

Evidence from the records

  • “'siSwati-first' mobile app with connected vital data, care reminders and consent-based family sharing”
  • “Product in pre-launch (waiting list); no public users or partners.”
  • “chronic care led by the doctor and monitored by Eva”
If it works
A joint maternal-health pilot proposal to an Eswatini or Botswana health authority.
First step
Schedule a call with VytalBridge to map its Doctor Hub to TIBOK's workspace model.

Market entry1

A local partner where they want to go

Power Teramed’s Angolan teleconsultation and corporate health offer as white-label

Teramed holds the local positioning in Angola (corporate health, 24/7 GP teleconsultation, hospital booking) but shows no traction or disclosed technology depth; TIBOK offers exactly the white-label OS model already signed with C-Care. Teramed would become a Portuguese-speaking distributor, opening Angola without TIBOK building a local entity.

40%confidence

Evidence from the records

  • “Baika Corporate (employee health management for companies), 24/7 teleconsultation with general practitioners”
  • “No public evidence of traction found”
  • “distribute it under their own brand, on their own WhatsApp and phone numbers, with one workspace per client (country, language, time zone)”
  • “First white-label distributor contract signed with C-Care Madagascar (19 November 2026)”
If it works
A distributor contract for Angola modelled on C-Care, starting with Baika Corporate clients.
First step
Contact Teramed's CTO via Champions Network with a C-Care-style distributor term sheet and a Portuguese Eva demo.

Co-development2

An integration or joint product

Plug a CE-marked dermatology AI into TIBOK’s photo dermatology

TIBOK already offers dermatology by photo; Legit.Health is a CE-marked medical device scoring skin disease severity from images. Integrating it adds certified decision support to TIBOK's flow and gives Legit.Health distribution in African and Indian Ocean markets it does not cover.

30%confidence

Evidence from the records

  • “dermatology by photo”
  • “CE-marked medical device (ISO 13485)”
  • “Computer vision and deep learning on skin images”
If it works
A per-analysis integration fee model and a joint offer to insurers.
First step
Request Legit.Health's API documentation and pricing for per-image analysis.

Add photo-based anemia screening to SilentCheck and maternal pathways

Anemia is highly prevalent in TIBOK's target markets and usually requires a blood test; Monere screens risk from a smartphone photo of the lower eyelid. Adding it to Eva's pathways extends TIBOK's no-blood-test screening portfolio and gives Monere a real-world deployment channel.

25%confidence

Evidence from the records

  • “SilentCheck (22 questions, no blood test, biological age, built on Framingham, IDRS and SCORED)”
  • “NiADA app (analysis of a smartphone photo of the lower eyelid)”
  • “AI anemia detection solution that assesses risk in a few seconds, without a blood test.”
If it works
A validation pilot in Mauritius or Madagascar comparing photo screening to lab haemoglobin.
First step
Propose to Monere a joint validation protocol using TIBOK's connected labs as reference.

Investors1

A fund whose thesis fits

Bring Axian into the seed as a Madagascar/Indian Ocean strategic

Axian invests $0.05–1.5M at seed/Series A in AI and technology for Africa and the Indian Ocean, with Madagascar in its geographies; TIBOK's C-Care Madagascar launch makes it a natural strategic co-investor in the USD 1.8M seed. No network warm path identified.

25%confidence

Evidence from the records

  • “Technology for African individuals, SMEs and corporates: AI infrastructure, cybersecurity, data sovereignty, digital assets, fintech; 1-5% minority stakes.”
  • “USD 1.8M targeted”
If it works
A strategic ticket plus telecom/distribution access in Madagascar.
First step
Send Axian's investment team the seed memo highlighting the C-Care Madagascar go-live in January 2027.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Most promising across the network

587 opportunities analysed
  1. Critical Medical DeviceswithLove LifesciencesPeers

    Share drug-delivery device lessons with Love Lifesciences

    Both are US pre-seed drug-delivery device companies founded around a clinical pain point. Exchanging contract manufacturer, regulatory consultant and pharma-partnering contacts saves both time and money.

    30%
  2. Roam TechnologieswithByonyksPeers

    Learn from Byonyks' 2025 FDA class II clearance and US launch set-up

    Byonyks obtained FDA 510(k) clearance for a home-therapy device and is setting up US infrastructure, the exact path Roam must follow. A founder exchange can shorten Roam's regulatory and DME launch planning.

    30%
  3. Lampsy HealthwithLegit.HealthPeers

    Learn from Legit.Health's medical-device certification path

    Legit.Health took an AI medical device through CE marking with an ISO 13485 quality system in Iberia; Lampsy faces the same regulatory steps. A founder exchange shortens the learning curve.

    30%
  4. AlgatekwithAtoz Carbon Cycle PlatformPeers

    Regional microalgae alliance for Malaysia

    Atoz builds nature-based carbon solutions with microalgae in Malaysia but has no public traction; Algatek has installed units at Indonesian SOEs. Sharing technology, MRV methods and possibly licensing Algatek units into Malaysia would give both a bigger regional story.

    25%
  5. Atoz Carbon Cycle PlatformwithAlgatekPeers

    Learn from a deployed microalgae business next door

    Algatek has leased microalgae units to Indonesian SOEs and claims IoT-monitored capture; Atoz has a prototype. Licensing or co-selling Algatek's MicroForest in Malaysia could give Atoz an immediate product while it builds its platform.

    25%
  6. Love LifescienceswithCritical Medical DevicesPeers

    Share FDA and QMS learnings between two pre-clearance drug-delivery devices

    Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

    25%
  7. ZymoChemwithYeast Bay BioPeers

    Davis fermentation network and scale-up playbook

    ZymoChem's CEO trained at UC Davis, where Yeast Bay Bio was founded in 2025. Sharing contract-fermentation contacts, scale-up lessons and DOE/grant experience is low cost and high value for a seed-stage fermentation company.

    25%
  8. LainTechwithBaniqlPeers

    Battery-metals alliance between two atmospheric leaching processes

    Baniql produces battery-grade nickel MHP from Indonesian laterites at low temperature and pressure; Lain Tech treats sulfides containing cobalt and nickel. Together they can present battery offtakers a complementary low-carbon hydrometallurgy portfolio and share know-how on catalysts and scale-up.

    25%
  9. Amass BiosystemswithRegenratePeers

    Borrow Regenrate’s contract-farming model for intercrops

    Regenrate monetises the intercrop period in France with free seed and guaranteed purchase prices — the same farmer-economics problem Amass must solve. Its contract design is a template for Amass' farmer offer.

    20%
  10. BILIXwithPleryon TherapeuticsPeers

    Exchange on polymer-drug CMC and Asian licensing

    Both companies develop polymer-based therapeutics at Series A in Asia. Sharing CMC suppliers, regulatory strategy and licensing contacts reduces cost and time for both.

    20%
  11. Pleryon TherapeuticswithBioSapienPeers

    Compare local-delivery regulatory playbooks

    Both companies build localised, extended-release delivery platforms (BioSapien in oncology implants, Pleryon in ophthalmology). Sharing regulatory and CMC learnings on biodegradable delivery systems reduces costly missteps.

    20%
  12. RegenratewithAmass BiosystemsPeers

    Exchange intercrop-for-bioenergy playbooks

    Amass grows a bioenergy crop alongside corn for biomass; Regenrate grows camelina between crops for biofuel. Both sell farmer income diversification to energy buyers and can share off-take and agronomy learnings across EU/US.

    20%
  13. FluvwithTausiPeers

    Share the gig-provider OS playbook

    Tausi runs an AI-powered operating system for independent beauticians with verified providers and a commission model. Fluv faces the same supply-side problem with pet-sitters; exchanging verification, training and retention practices is useful for both.

    15%
  14. PromptendwithNeurath AIPeers

    AI reliability peer exchange

    Both address trust in AI outputs (Promptend for generated code, Neurath for model predictions) and sell to risk-averse engineering buyers; sharing go-to-market learnings on assurance products is useful.

    15%
  15. PsychoTechwithPromptendPeers

    Moldovan finalist cohort coordination

    Both represent Moldova at the SWC final; pooling travel, investor meetings and Startup Moldova support reduces cost, and PsychoTech could pilot Promptend on its client code.

    15%
  16. ShopperoowithPardon AIPeers

    Benchmark against Pardon AI's profitability agents

    Pardon AI sells AI agents that optimise revenue and margins for retail and food service and has been through Techstars. A founder exchange clarifies positioning and possible specialisation (pricing/assortment vs broader profitability).

    15%
  17. VIEROC AIwithWiseUnitPeers

    Exchange voice-agent and chat-agent learnings with WiseUnit

    WiseUnit sells an AI phone receptionist; VIEROC focuses on chat agents. Comparing pricing, churn and model costs, or white-labelling each other's channel, could help both small teams.

    15%
  18. SchoolACEwithKetzaiPeers

    Learn from Ketzai’s path to 40,000 teachers

    Ketzai solved teacher acquisition for AI lesson planning by aligning with official curricula; SchoolACE can learn its playbook and potentially share content tooling for Spanish-speaking US classrooms.

    15%

Similar profiles

Compatibility score with TIBOK

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.